AB02
Phase 3 Recruiting
1,100 enrolled
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
Phase 1 Recruiting
12 enrolled
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase 1/2 Recruiting
300 enrolled
panSOHO
Phase 2 Recruiting
111 enrolled
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Phase 3 Recruiting
286 enrolled
DP-04
Recruiting
100 enrolled
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Phase NA Recruiting
360 enrolled
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Phase 1/2 Recruiting
159 enrolled
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Phase 2 Recruiting
27 enrolled
EULAT
Recruiting
15,000 enrolled
Beacon-BTC
Phase 3 Recruiting
480 enrolled
iCaRe2
Recruiting
999,999 enrolled
FAPi-2
Recruiting
60 enrolled
Target-specific immunoPET Imaging of Digestive System Carcinoma
Phase NA Recruiting
400 enrolled
A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
Recruiting
1,800 enrolled
STALL
Phase NA Recruiting
850 enrolled
ROBOCOP
Phase NA Recruiting
94 enrolled
TRAP-BTC
Phase 2 Recruiting
24 enrolled
SAIB
Phase 2 Recruiting
60 enrolled
Bile Omics for Diagnosing Indeterminate Biliary Strictures
Recruiting
260 enrolled
NEOGB
Phase 3 Recruiting
114 enrolled
RUGB
Phase 2/3 Recruiting
249 enrolled
LIVELONG
Phase NA Recruiting
300 enrolled
Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
Phase 2/3 Recruiting
56 enrolled
The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer
Phase NA Recruiting
88 enrolled
QPCS
Recruiting
2,000 enrolled
The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
Recruiting
1,000 enrolled
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
Phase 2 Recruiting
50 enrolled